ANTICOAGULANT

PROBLEM TO BE SOLVED: To provide an anticoagulant which can be used for both a blood- corpuscle counting test and a blood coagulation test as the anticoagulant which is used for a blood test in a clinical test field. SOLUTION: This anticoagulant is an anticoagulant which is constituted of a citrate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AKAI YASUMASA, NISHIZAKI MIKIKO
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide an anticoagulant which can be used for both a blood- corpuscle counting test and a blood coagulation test as the anticoagulant which is used for a blood test in a clinical test field. SOLUTION: This anticoagulant is an anticoagulant which is constituted of a citrate and of a platelet membrane receptor inhibitor as an antiplatelet flocculant and which can be used for both a blood-corpuscle counting test and a blood coagulation test. The platelet membrane receptor inhibitor is preferably an anti-GpIIb/IIIa monoclonal antibody. In addition, the final concentration of the anti-GpIIb/IIIa monoclonal antibody is preferably at 27 mg/L or higher.